These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1819589)

  • 1. Synthesis of N alpha-Fmoc protected derivatives of S-(2,3-dihydroxypropyl)-cysteine and their application in peptide synthesis.
    Metzger JW; Wiesmüller KH; Jung G
    Int J Pept Protein Res; 1991 Dec; 38(6):545-54. PubMed ID: 1819589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations.
    Metzger J; Wiesmüller KH; Schaude R; Bessler WG; Jung G
    Int J Pept Protein Res; 1991 Jan; 37(1):46-57. PubMed ID: 2045219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous microwave-assisted solid-phase peptide synthesis using fmoc strategy. II. Racemization studies and water based synthesis of cysteine-containing peptides.
    Hojo K; Shinozaki N; Hara A; Onishi M; Fukumori Y; Ichikawa H
    Protein Pept Lett; 2013 Oct; 20(10):1122-8. PubMed ID: 23517723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated Fmoc-based solid-phase synthesis of peptide thioesters with self-purification effect and application in the construction of immobilized SH3 domains.
    Mende F; Beisswenger M; Seitz O
    J Am Chem Soc; 2010 Aug; 132(32):11110-8. PubMed ID: 20662535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis.
    Biron E; Kessler H
    J Org Chem; 2005 Jun; 70(13):5183-9. PubMed ID: 15960522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.
    Busnel O; Bi L; Dali H; Cheguillaume A; Chevance S; Bondon A; Muller S; Baudy-Floc'h M
    J Org Chem; 2005 Dec; 70(26):10701-8. PubMed ID: 16355988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response.
    Wiesmüller KH; Bessler WG; Jung G
    Int J Pept Protein Res; 1992; 40(3-4):255-60. PubMed ID: 1282504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The investigation of Fmoc-cysteine derivatives in solid phase peptide synthesis.
    McCurdy SN
    Pept Res; 1989; 2(1):147-52. PubMed ID: 2577698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Nalpha-Fmoc-cysteine(S-thiobutyl) derivatized oligodeoxynucleotides for the preparation of oligodeoxynucleotide-peptide hybrid molecules.
    Soukchareun S; Haralambidis J; Tregear G
    Bioconjug Chem; 1998; 9(4):466-75. PubMed ID: 9667948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins.
    DeOgny L; Pramanik BC; Arndt LL; Jones JD; Rush J; Slaughter CA; Radolf JD; Norgard MV
    Pept Res; 1994; 7(2):91-7. PubMed ID: 8012126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydropyranyl, a nonaromatic acid-labile Cys protecting group for Fmoc peptide chemistry.
    Ramos-Tomillero I; Rodríguez H; Albericio F
    Org Lett; 2015 Apr; 17(7):1680-3. PubMed ID: 25764355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient preparation of Fmoc-aminoacyl-N-ethylcysteine unit, a key device for the synthesis of peptide thioesters.
    Hojo H; Kobayashi H; Ubagai R; Asahina Y; Nakahara Y; Katayama H; Ito Y; Nakahara Y
    Org Biomol Chem; 2011 Oct; 9(19):6807-13. PubMed ID: 21842100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivatives of S-9-fluorenylmethyl-L-cysteine.
    Bodanszky M; Bednarek MA
    Int J Pept Protein Res; 1982 Nov; 20(5):434-7. PubMed ID: 7174206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of Fmoc-Thr[PO(OH)(OPOM)] for the preparation of peptide prodrugs containing phosphothreonine in fully protected form.
    Qian WJ; Lai CC; Kelley JA; Burke TR
    Chem Biodivers; 2014 May; 11(5):784-91. PubMed ID: 24827688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urethane-protected alpha-amino acid N-carboxyanhydrides and peptide synthesis.
    Fuller WD; Goodman M; Naider FR; Zhu YF
    Biopolymers; 1996; 40(2):183-205. PubMed ID: 8785363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of N-(Hydroxy)amide- and N-(Hydroxy)thioamide-containing peptides.
    Wang L; Phanstiel O
    J Org Chem; 2000 Mar; 65(5):1442-7. PubMed ID: 10814107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-phase synthesis of N-nosyl- and N-Fmoc-N-methyl-alpha-amino acids.
    Di Gioia ML; Leggio A; Liguori A; Perri F
    J Org Chem; 2007 May; 72(10):3723-8. PubMed ID: 17439178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of the very acid-sensitive Fmoc-Cys(Mmt)-OH and its application in solid-phase peptide synthesis.
    Barlos K; Gatos D; Hatzi O; Koch N; Koutsogianni S
    Int J Pept Protein Res; 1996 Mar; 47(3):148-53. PubMed ID: 8740963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A one-pot procedure for the preparation of N-9-fluorenylmethyloxycarbonyl-α-amino diazoketones from α-amino acids.
    Siciliano C; De Marco R; Guidi LE; Spinella M; Liguori A
    J Org Chem; 2012 Dec; 77(23):10575-82. PubMed ID: 23146162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.